Lymphoma patients on 'Watch and Wait' may be more anxious than treated ones

NCT ID NCT07173790

First seen Sep 30, 2025 · Last updated Jun 22, 2026 · Updated 21 times

Summary

This study looks at how watchful waiting affects the quality of life of 250 Korean patients with slow-growing lymphomas like CLL and follicular lymphoma. Participants fill out surveys about their physical and emotional well-being. The goal is to understand if the anxiety of monitoring without treatment harms patients more than the disease itself.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Korea UniversityKorea University Guro Hospital

    Seoul, Guro-gu, 08308, South Korea

  • Samsung Medical Center

    Seoul, Gangnam-gu, 06351, South Korea

  • Seoul National University Hospital

    Seoul, Jongno-gu, South Korea

  • The Catholic University of Korea

    Seoul, Seocho-gu, 06591, South Korea

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could show that watchful waiting causes significant distress, leading to better support or earlier treatment for patients.

What could go wrong

This is an observational study, not a treatment trial. It only measures patient experiences and cannot prove whether watchful waiting is harmful or beneficial.

Conditions

The condition(s) this trial relates to.

B-cell chronic lymphocytic leukemia chronic lymphocytic leukemia/small lymphocytic lymphoma follicular lymphoma Lymphoma, B-Cell, Marginal Zone lymphoplasmacytic lymphoma marginal zone lymphoma Waldenstrom macroglobulinemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.